Similar articles

• Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).

  van Veldhuisen DJ, Cohen-Solal A, Böhm M, Anker SD, Babalis D, Roughton M, Coats AJ, Poole-Wilson PA, Flather MD; SENIORS Investigators. van Veldhuisen DJ, et al. J Am Coll Cardiol. 2009 Jun 9;53(23):2150-8. doi: 10.1016/j.jacc.2009.02.046. J Am Coll Cardiol. 2009. PMID: 19497441 Clinical Trial.
• The effect of beta-blockers on mortality in heart failure with preserved ejection fraction: A meta-analysis of observational cohort and randomized controlled studies.

  Fukuta H, Goto T, Wakami K, Ohte N. Fukuta H, et al. Int J Cardiol. 2017 Feb 1;228:4-10. doi: 10.1016/j.ijcard.2016.11.239. Epub 2016 Nov 11. Int J Cardiol. 2017. PMID: 27863360
• Optimal Use of Beta-Blockers for Congestive Heart Failure.

  Lee HY, Baek SH. Lee HY, et al. Circ J. 2016;80(3):565-71. doi: 10.1253/circj.CJ-16-0101. Epub 2016 Feb 19. Circ J. 2016. PMID: 26902451 Review.
• The cellular and physiologic effects of beta blockers in heart failure.

  Sabbah HN. Sabbah HN. Clin Cardiol. 1999 Oct;22 Suppl 5:V16-20. Clin Cardiol. 1999. PMID: 10526699 Review.
• Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.

  Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB; OPTIMIZE-HF Investigators and Hospitals. Fonarow GC, et al. J Am Coll Cardiol. 2007 Aug 21;50(8):768-77. doi: 10.1016/j.jacc.2007.04.064. Epub 2007 Aug 6. J Am Coll Cardiol. 2007. PMID: 17707182